Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.65 |
| ▸ | CNR1 | P21554 | 1/20 | 0.54 |
| ▸ | CNR2 | P34972 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.47 |
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.46 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.46 |
| ▸ | NAAA | Q02083 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17560018 | 1.00 | FAAH (0.65) | FAAHCNR1CNR2ALDH1A1GPR84 | |
| SCHEMBL17560003 | 1.00 | FAAH (0.65) | FAAHCNR1CNR2ALDH1A1GPR84 | |
| SCHEMBL29923778 | 0.92 | FAAH (0.54) | FAAHCNR1CNR2ALDH1A1CA1 | |
| SCHEMBL4838991 | 0.92 | FAAH (0.54) | FAAHCNR1CNR2ALDH1A1CA1 | |
| SCHEMBL15294505 | 0.89 | FAAH (0.65) | FAAHCNR1CNR2ALDH1A1CA1 | |
| SCHEMBL15294509 | 0.89 | FAAH (0.65) | FAAHCNR1CNR2ALDH1A1CA1 | |
| SCHEMBL7223822 | 0.89 | FAAH (0.65) | FAAHCNR1CNR2ALDH1A1CA1 | |
| SCHEMBL15294506 | 0.89 | FAAH (0.65) | FAAHCNR1CNR2ALDH1A1CA1 | |
| SCHEMBL15294508 | 0.89 | FAAH (0.65) | FAAHCNR1CNR2ALDH1A1CA1 | |
| SCHEMBL7219470 | 0.89 | FAAH (0.65) | FAAHCNR1CNR2ALDH1A1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103153276-B | Comprise the cosmetic composition of super molecular compound and the specific oil can setting up hydrogen bond | L'OREAL (FR) | 2015-09-30 | — | — | CN | claimed |
| CN-103153276-A | Cosmetic composition comprising a supramolecular compound capable of establishing hydrogen bonds, and a particular oil | OREAL | 2013-06-12 | — | — | CN | claimed |
| CN-1977792-B | Cosmetic composition comprising a cation, a liquid fatty substance and a sorbitan ester, and cosmetic treatment process | OREAL | 2012-03-21 | — | — | CN | claimed |
| CN-101856314-A | The make-up composition that comprises block polymer and non-volatile silicone oil | OREAL | 2010-10-13 | — | — | CN | claimed |
| CN-1977792-A | Cosmetic composition comprising a cation, a liquid fatty substance and a sorbitan ester, and cosmetic treatment process | OREAL (FR) | 2007-06-13 | — | — | CN | claimed |
| CN-1226986-C | Cosmetics composition contg. surface stabilized polymer particle dispersion in liquid fat phase in form of emulsion | OREAL (FR) | 2005-11-16 | — | — | CN | claimed |
| CN-1636539-A | Cosmetic composition comprising a block polymer and a non-volatile silicone oil | OREAL (FR) | 2005-07-13 | — | — | CN | claimed |
| CN-1256119-A | Cosmetic composition containg at least one kind of amorphous poly(cyclenes) or amorphous poly(cyclenes) mixture and its use | OREAL (FR) | 2000-06-14 | — | — | CN | claimed |
| CN-1254551-A | Non-metastatic beautifying composition containing dispersed polymer particles and special rehologic reagent | OREAL (FR) | 2000-05-31 | — | — | CN | claimed |
| CN-1249171-A | Cosmetics composition contg. surface stabilized polymer particle dispersion in liquid fat phase in form of emulsion | OREAL (FR) | 2000-04-05 | — | — | CN | claimed |
| CN-1225257-A | Non-transfusion cosmetics contg. non-film-forming polymer particles existing in partially non-volatile liquid aoliphatic phase | OREAL (FR) | 1999-08-11 | — | — | CN | claimed |
| EP-4676226-A1 | ANTIFUNGAL COMPOSITIONS COMPRISING NATAMYCIN | Patent Nata B.V. (NL) | 2026-01-14 | — | — | EP | disclosed |
| WO-2024186207-A1 | ANTIFUNGAL COMPOSITIONS COMPRISING NATAMYCIN | CERADIS PATENT B.V. (NL) | 2024-09-12 | — | — | WO | disclosed |
| US-20230413824-A1 | AGROCHEMICAL COMPOSITION COMPRISING 3-SUBSTITUTED PHENYLAMIDINE COMPOUNDS AND USE THEREOF | PI INDUSTRIES LTD. (IN) | 2023-12-28 | — | — | US | disclosed |
| EP-4250926-A1 | AGROCHEMICAL COMPOSITION COMPRISING 3-SUBSTITUTED PHENYLAMIDINE COMPOUNDS AND USE THEREOF | PI Industries Ltd. (IN) | 2023-10-04 | — | — | EP | disclosed |
| CN-1248432-A | Cosmetic composition comprising a film-forming polymer, a polyalphaolefin and a liquid fatty phase | OREAL (FR) | 2000-03-29 | — | — | CN | disclosed |
| CN-1225257-A | Non-transfusion cosmetics contg. non-film-forming polymer particles existing in partially non-volatile liquid aoliphatic phase | OREAL (FR) | 1999-08-11 | — | — | CN | disclosed |
| CN-1215325-A | Cosmetic use of rigid gels and composition for cosmetic or skincare | OREAL (FR) | 1999-04-28 | — | — | CN | disclosed |
| CN-1185732-A | Expanded starch-based solid composition comprising sized spherical polyamide particles and its topical use | OREAL (FR) | 1998-06-24 | — | — | CN | disclosed |
| CN-1129557-A | Compacted powder composition for cosmetics and the preparation thereof | OREAL (FR) | 1996-08-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230413824-A1 | AGROCHEMICAL COMPOSITION COMPRISING 3-SUBSTITUTED PHENYLAMIDINE COMPOUNDS AND USE THEREOF | CBR3, PFAS, PAH | FAAH 2125/4885CNR1 828/4885CNR2 1016/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.